GRAND RAPIDS, MI -- (MARKET WIRE) -- April 10, 2007 -- Oncologix Tech Inc. (OTCBB: OCLG) announced today that its wholly owned subsidiary Oncologix Corporation (“Oncologix”) has decided to update its development plans to add a Feasibility Clinical Study with its Oncosphere System for the treatment of liver cancers. Oncologix plans to submit a request for approval from the Food and Drug Administration (FDA) to conduct the Feasibility Clinical Study before the end of 2007.
